Posts
December 28 2011
Oculus Innovative Sciences, Inc. announced the closing of their registered direct offering in the amount of $2,081,100. EG&S acted as counsel to the Placement Agent.
December 28 2011
Quadrant 4 Systems Corporation announced the closing of their private placement in the amount of $800,000. EG&S acted as counsel to the Investor.
December 27 2011
Catasys, Inc. announced the closing of their registered direct offering in the amount of $974,999. EG&S acted as counsel to the Placement Agent.
December 21 2011
StemCells, Inc. announced the closing of their underwritten public offering in the amount of $10,000,000. EG&S acted as counsel to the Underwriter.
December 13 2011
PhotoMedex, Inc., a NASDAQ listed company, and Radiancy, Inc., a private Delaware company, announced the completion of their merger. Pursuant to the merger, the former stockholders of Radiancy received shares of Photomedex valued on the date of closing at approximately $235 million and collectively own approximately 75% of PhotoMedex, Inc. following the merger. Radiancy became a majority-owned subsidiary of PhotoMedex. EG&S acted as counsel to Radiancy.
December 13 2011
Cell Therapeutics Inc. announced the closing of their registered direct in the amount of $20,000,000. EG&S acted as counsel to the Placement Agent.
December 07 2011
Capitol C Holdings LLC announced the completion of its refinancing of senior secured debt with NCB, FSB. EG&S acted as counsel to Capitol C Holdings.
December 06 2011
Celsion Corporation announced the closing of their PIPE offering in the amount of $15,000,00. EG&S acted as counsel to the Placement Agent.